Knight Therapeutics Inc. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
4:02 pm
Sale
2026-03-3113G60 DEGREES PHARMACEUTICALS INC
SXTP
Knight Therapeutics Inc.0
0.000%
-8,475decrease
(Position Closed)
Filing
History
2025-06-13
4:06 pm
Purchase
2025-06-1113GSYNERGY CHC CORP COM
SNYR
Knight Therapeutics Inc.1,911,414
19.900%
428,570increase
(+28.90%)
Filing
History
2025-03-20
4:01 pm
Purchase
2024-12-3113GSYNERGY CHC CORP COM
SNYR
Knight Therapeutics Inc.1,482,844
17.030%
1,482,844increase
(New Position)
Filing
History
2024-11-13
4:01 pm
Purchase
2024-09-3013G60 DEGREES PHARMACEUTICALS INC
SXTP
Knight Therapeutics Inc.8,475
9.100%
8,475increase
(New Position)
Filing
History